top of page
Sorting Medicine

ALS | Parkinson's Disease | Cancer
Stroke | Alzheimer's Disease

A Robust Pipeline

of Disease Modifying
Medicines

ASHA-091

Alzheimer's, Parkinson's
ALS, Stroke, Post-viral Illness

ASHA-624

ALS, MS, Glaucoma
Peripheral Neuropathies

ASHA-044

Colorectal Cancer
Immuno-oncology

Undisclosed

PRISM™ Novel Design Program

Novel Design         Lead Optimization          IND-Enabling          Clinical Trials         

Target - Mitochondrial DRP1

Target - SARM1

Target - Beta Catenin

Target - Multiple

Target Overview - Lead Development Candidate Programs

image.png

ASHA-091 is a highly selective inhibitor of the key mitochondria regulatory protein DRP1. ASHA-091 restores mitochondria to a healthy functional state.

Mitochondrial dysfunction is a key driver of neurodegeneration and certain types of infectious and post-infection illness. ASHA-091 has broad therapeutic indications with demonstrate disease modifying efficacy and robust safety.

bottom of page